China’s cytology market is worth nearly USD30 million in 2007 and expected to grow by over 15% CAGR over the next 5 years.

China is still in the early stages of cervical cancer prevention. Its immature prevention mechanism has resulted in one of the highest incidence of the disease in Asia, where 100,000 women are diagnosed with cervical cancer in China every year. However, this situation is slowly changing as the government step up efforts to raise awareness and enhance prevention efforts.